Christopher Macdonell Coley, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Community-Acquired Infections | 19 | 2002 | 465 | 0.410 |
Why?
|
Pneumonia | 20 | 2002 | 2133 | 0.400 |
Why?
|
Medication Systems, Hospital | 5 | 2008 | 158 | 0.350 |
Why?
|
Prostate-Specific Antigen | 8 | 2001 | 2494 | 0.310 |
Why?
|
Medical Order Entry Systems | 5 | 2017 | 545 | 0.280 |
Why?
|
Students | 4 | 2007 | 1654 | 0.260 |
Why?
|
Medication Errors | 6 | 2010 | 798 | 0.240 |
Why?
|
Physical Examination | 4 | 2001 | 1237 | 0.220 |
Why?
|
Musculoskeletal Diseases | 4 | 2007 | 581 | 0.210 |
Why?
|
Computers | 2 | 2004 | 612 | 0.200 |
Why?
|
Medical Records Systems, Computerized | 4 | 2009 | 1205 | 0.190 |
Why?
|
Cumulative Trauma Disorders | 1 | 2000 | 147 | 0.170 |
Why?
|
Arm Injuries | 1 | 2000 | 160 | 0.170 |
Why?
|
Arm | 1 | 2002 | 589 | 0.160 |
Why?
|
Thallium Radioisotopes | 4 | 1992 | 139 | 0.160 |
Why?
|
Dipyridamole | 4 | 1992 | 145 | 0.160 |
Why?
|
Severity of Illness Index | 12 | 2011 | 15540 | 0.150 |
Why?
|
Preoperative Care | 5 | 1996 | 2250 | 0.140 |
Why?
|
Prostatic Neoplasms | 8 | 2001 | 11124 | 0.120 |
Why?
|
Decision Support Systems, Clinical | 4 | 2017 | 1164 | 0.120 |
Why?
|
Videotape Recording | 1 | 2015 | 352 | 0.110 |
Why?
|
Ambulatory Care | 5 | 1998 | 2708 | 0.110 |
Why?
|
Intraoperative Care | 1 | 1996 | 767 | 0.100 |
Why?
|
Clinical Pharmacy Information Systems | 2 | 2009 | 103 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2017 | 783 | 0.100 |
Why?
|
Athletic Injuries | 1 | 2000 | 1154 | 0.090 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2011 | 58 | 0.090 |
Why?
|
Medication Reconciliation | 1 | 2010 | 151 | 0.080 |
Why?
|
Mass Screening | 4 | 1997 | 5255 | 0.080 |
Why?
|
Patient Preference | 1 | 2015 | 890 | 0.080 |
Why?
|
Decision Making | 3 | 2015 | 3887 | 0.070 |
Why?
|
Dermatomyositis | 1 | 2009 | 224 | 0.070 |
Why?
|
Coronary Disease | 5 | 1994 | 6077 | 0.070 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2015 | 980 | 0.070 |
Why?
|
Medical Audit | 1 | 2008 | 467 | 0.070 |
Why?
|
Anesthesia, Conduction | 1 | 2010 | 238 | 0.070 |
Why?
|
Resuscitation Orders | 2 | 2015 | 269 | 0.070 |
Why?
|
Intubation, Intratracheal | 1 | 2015 | 1364 | 0.070 |
Why?
|
User-Computer Interface | 3 | 2010 | 1431 | 0.070 |
Why?
|
Forms and Records Control | 1 | 2007 | 160 | 0.070 |
Why?
|
Medicare | 4 | 1995 | 6566 | 0.070 |
Why?
|
Pain | 1 | 2000 | 4986 | 0.060 |
Why?
|
Myocardial Ischemia | 1 | 1996 | 2148 | 0.060 |
Why?
|
Observation | 1 | 2007 | 312 | 0.060 |
Why?
|
Probability | 4 | 2002 | 2505 | 0.060 |
Why?
|
Hospitalization | 5 | 2005 | 10262 | 0.060 |
Why?
|
Medical History Taking | 1 | 2008 | 783 | 0.060 |
Why?
|
Surgical Procedures, Operative | 1 | 1996 | 1876 | 0.060 |
Why?
|
Rectum | 3 | 2001 | 904 | 0.060 |
Why?
|
Continuity of Patient Care | 2 | 2008 | 1049 | 0.060 |
Why?
|
Inpatients | 1 | 2015 | 2518 | 0.060 |
Why?
|
Likelihood Functions | 2 | 1997 | 1005 | 0.050 |
Why?
|
Length of Stay | 4 | 2000 | 6309 | 0.050 |
Why?
|
Nova Scotia | 5 | 2000 | 34 | 0.050 |
Why?
|
Critical Illness | 1 | 2015 | 2670 | 0.050 |
Why?
|
Biopsy, Needle | 2 | 1997 | 1641 | 0.050 |
Why?
|
Venous Thrombosis | 1 | 2010 | 1239 | 0.050 |
Why?
|
Male | 39 | 2015 | 350118 | 0.050 |
Why?
|
Patient Admission | 4 | 2008 | 1380 | 0.040 |
Why?
|
Aged | 30 | 2015 | 163280 | 0.040 |
Why?
|
Anesthesiology | 1 | 2010 | 1060 | 0.040 |
Why?
|
Pneumonia, Pneumococcal | 1 | 2000 | 127 | 0.040 |
Why?
|
Middle Aged | 31 | 2015 | 213383 | 0.040 |
Why?
|
Sex Distribution | 2 | 2002 | 2297 | 0.040 |
Why?
|
Radionuclide Imaging | 5 | 2001 | 2031 | 0.040 |
Why?
|
Practice Guidelines as Topic | 3 | 2010 | 7279 | 0.040 |
Why?
|
Humans | 53 | 2017 | 744343 | 0.040 |
Why?
|
Risk Factors | 16 | 2007 | 72290 | 0.040 |
Why?
|
Age Distribution | 3 | 2002 | 2902 | 0.040 |
Why?
|
Pennsylvania | 4 | 2000 | 613 | 0.040 |
Why?
|
Prospective Studies | 15 | 2015 | 53288 | 0.040 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 194 | 0.030 |
Why?
|
Age Factors | 7 | 2001 | 18370 | 0.030 |
Why?
|
Female | 31 | 2015 | 380194 | 0.030 |
Why?
|
Predictive Value of Tests | 6 | 2002 | 15076 | 0.030 |
Why?
|
Prevalence | 4 | 2000 | 15226 | 0.030 |
Why?
|
Patient Discharge | 3 | 2008 | 3313 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2008 | 3843 | 0.030 |
Why?
|
Adult | 23 | 2004 | 214055 | 0.030 |
Why?
|
Hospital Costs | 1 | 2000 | 985 | 0.030 |
Why?
|
Logistic Models | 3 | 2000 | 13408 | 0.030 |
Why?
|
Unnecessary Procedures | 1 | 2017 | 432 | 0.030 |
Why?
|
Neoplasm Staging | 4 | 2001 | 11031 | 0.030 |
Why?
|
Prostatic Hyperplasia | 1 | 1997 | 523 | 0.030 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2759 | 0.030 |
Why?
|
Models, Economic | 1 | 1997 | 713 | 0.030 |
Why?
|
Reimbursement Mechanisms | 2 | 1995 | 670 | 0.030 |
Why?
|
Risk | 7 | 2002 | 9687 | 0.030 |
Why?
|
Insurance, Health, Reimbursement | 1 | 1995 | 397 | 0.030 |
Why?
|
United States | 9 | 2002 | 69872 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2000 | 6365 | 0.030 |
Why?
|
Reference Standards | 1 | 1995 | 1025 | 0.030 |
Why?
|
Treatment Outcome | 9 | 2011 | 63114 | 0.030 |
Why?
|
Cause of Death | 1 | 2002 | 3584 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 1994 | 646 | 0.020 |
Why?
|
Algorithms | 5 | 2001 | 13881 | 0.020 |
Why?
|
Vascular Surgical Procedures | 2 | 1990 | 1475 | 0.020 |
Why?
|
Deoxycholic Acid | 1 | 1990 | 54 | 0.020 |
Why?
|
Ursodeoxycholic Acid | 1 | 1990 | 72 | 0.020 |
Why?
|
Odds Ratio | 2 | 2000 | 9849 | 0.020 |
Why?
|
Reproducibility of Results | 3 | 2009 | 19905 | 0.020 |
Why?
|
Cost-Benefit Analysis | 4 | 1997 | 5391 | 0.020 |
Why?
|
Anti-Infective Agents | 1 | 1998 | 972 | 0.020 |
Why?
|
Cohort Studies | 8 | 2011 | 40561 | 0.020 |
Why?
|
Monitoring, Intraoperative | 1 | 1996 | 957 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2002 | 3679 | 0.020 |
Why?
|
Intraoperative Complications | 1 | 1996 | 1198 | 0.020 |
Why?
|
Drug Therapy, Computer-Assisted | 1 | 2010 | 204 | 0.020 |
Why?
|
Cholelithiasis | 1 | 1990 | 414 | 0.020 |
Why?
|
Cholecystectomy | 1 | 1990 | 395 | 0.020 |
Why?
|
Aged, 80 and over | 7 | 2015 | 57776 | 0.020 |
Why?
|
Comorbidity | 5 | 2002 | 10388 | 0.020 |
Why?
|
Prostate | 1 | 1995 | 1774 | 0.020 |
Why?
|
Program Evaluation | 1 | 1995 | 2488 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 1997 | 1956 | 0.020 |
Why?
|
Software Design | 1 | 2006 | 176 | 0.020 |
Why?
|
Linear Models | 2 | 2010 | 5952 | 0.020 |
Why?
|
Postoperative Complications | 3 | 1996 | 15295 | 0.020 |
Why?
|
Texas | 1 | 2007 | 392 | 0.020 |
Why?
|
Hospitals, University | 2 | 1998 | 571 | 0.020 |
Why?
|
Multivariate Analysis | 4 | 2002 | 12245 | 0.020 |
Why?
|
Anti-Bacterial Agents | 3 | 2000 | 7181 | 0.020 |
Why?
|
Life Expectancy | 3 | 2001 | 1184 | 0.020 |
Why?
|
Efficiency | 1 | 2008 | 462 | 0.020 |
Why?
|
Anesthesia | 1 | 1996 | 1561 | 0.020 |
Why?
|
Hospital Information Systems | 1 | 2007 | 395 | 0.020 |
Why?
|
Medical Staff, Hospital | 1 | 2008 | 603 | 0.010 |
Why?
|
Sensitivity and Specificity | 3 | 2011 | 14722 | 0.010 |
Why?
|
Organizational Innovation | 1 | 2006 | 559 | 0.010 |
Why?
|
Nerve Block | 1 | 2010 | 644 | 0.010 |
Why?
|
Radiography | 3 | 2001 | 7023 | 0.010 |
Why?
|
Societies, Medical | 2 | 2010 | 3743 | 0.010 |
Why?
|
Myocardial Infarction | 2 | 1996 | 11727 | 0.010 |
Why?
|
Risk Assessment | 3 | 2002 | 23338 | 0.010 |
Why?
|
Boston | 3 | 2000 | 9313 | 0.010 |
Why?
|
Ultrasonography | 1 | 1995 | 5985 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1827 | 0.010 |
Why?
|
ROC Curve | 2 | 2002 | 3527 | 0.010 |
Why?
|
Universities | 1 | 2007 | 956 | 0.010 |
Why?
|
Utilization Review | 1 | 2002 | 392 | 0.010 |
Why?
|
Quality of Life | 3 | 2011 | 12804 | 0.010 |
Why?
|
Blood Gas Analysis | 1 | 2001 | 383 | 0.010 |
Why?
|
Cryotherapy | 1 | 2001 | 155 | 0.010 |
Why?
|
Diabetes Mellitus | 2 | 1989 | 5751 | 0.010 |
Why?
|
Prostatectomy | 2 | 2001 | 1890 | 0.010 |
Why?
|
Upper Extremity | 1 | 2004 | 648 | 0.010 |
Why?
|
Data Collection | 1 | 2008 | 3341 | 0.010 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2212 | 0.010 |
Why?
|
Health Services | 1 | 2004 | 758 | 0.010 |
Why?
|
Survival Analysis | 2 | 2002 | 10252 | 0.010 |
Why?
|
Oximetry | 1 | 2001 | 471 | 0.010 |
Why?
|
Lung | 1 | 1996 | 9856 | 0.010 |
Why?
|
Erythromycin | 1 | 1997 | 120 | 0.010 |
Why?
|
Immunocompetence | 1 | 1997 | 137 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2010 | 3068 | 0.010 |
Why?
|
Pelvis | 1 | 2001 | 730 | 0.010 |
Why?
|
Canada | 1 | 2002 | 2065 | 0.010 |
Why?
|
Cost Savings | 1 | 2000 | 926 | 0.010 |
Why?
|
Hospital Mortality | 2 | 2002 | 5317 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2002 | 12354 | 0.010 |
Why?
|
Streptococcus pneumoniae | 1 | 2000 | 714 | 0.010 |
Why?
|
Health Care Surveys | 1 | 2002 | 2453 | 0.010 |
Why?
|
Lymph Node Excision | 1 | 2001 | 1261 | 0.010 |
Why?
|
Anticoagulants | 1 | 2010 | 4599 | 0.010 |
Why?
|
Cross-Sectional Studies | 2 | 2007 | 25043 | 0.010 |
Why?
|
Blood Glucose | 1 | 1989 | 6256 | 0.010 |
Why?
|
Cost of Illness | 1 | 2004 | 1859 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2000 | 12959 | 0.010 |
Why?
|
Pneumonia, Bacterial | 1 | 1996 | 316 | 0.010 |
Why?
|
Bacteremia | 1 | 2000 | 962 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1996 | 338 | 0.010 |
Why?
|
Pilot Projects | 1 | 2006 | 8324 | 0.010 |
Why?
|
Hospitals, Teaching | 1 | 1998 | 1179 | 0.010 |
Why?
|
Time Factors | 3 | 2002 | 40075 | 0.010 |
Why?
|
Retrospective Studies | 5 | 2007 | 77449 | 0.010 |
Why?
|
Recurrence | 2 | 1998 | 8340 | 0.010 |
Why?
|
Software | 1 | 2007 | 4443 | 0.010 |
Why?
|
Follow-Up Studies | 3 | 2001 | 39050 | 0.010 |
Why?
|
Treatment Failure | 1 | 1998 | 2618 | 0.010 |
Why?
|
Survival Rate | 2 | 1996 | 12788 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 1997 | 2886 | 0.010 |
Why?
|
Combined Modality Therapy | 2 | 1995 | 8642 | 0.010 |
Why?
|
Cryosurgery | 1 | 1995 | 453 | 0.010 |
Why?
|
Prognosis | 3 | 1997 | 29063 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2001 | 6895 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2001 | 4851 | 0.010 |
Why?
|
Bone and Bones | 1 | 2001 | 2575 | 0.010 |
Why?
|
Outpatients | 1 | 1997 | 1486 | 0.010 |
Why?
|
Glycosuria | 1 | 1989 | 43 | 0.010 |
Why?
|
Drug Evaluation | 1 | 1990 | 647 | 0.010 |
Why?
|
Biopsy | 1 | 2001 | 6756 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1991 | 585 | 0.010 |
Why?
|
Radiotherapy | 1 | 1995 | 1533 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 2002 | 7785 | 0.000 |
Why?
|
Pregnancy in Diabetics | 1 | 1988 | 179 | 0.000 |
Why?
|
Electrocardiography | 2 | 1991 | 6442 | 0.000 |
Why?
|
Adolescent | 3 | 2002 | 85781 | 0.000 |
Why?
|
Blood Glucose Self-Monitoring | 1 | 1989 | 434 | 0.000 |
Why?
|
Glucose Tolerance Test | 1 | 1989 | 1150 | 0.000 |
Why?
|
Regression Analysis | 1 | 1995 | 6459 | 0.000 |
Why?
|
Angina Pectoris | 1 | 1989 | 977 | 0.000 |
Why?
|
Massachusetts | 1 | 1998 | 8663 | 0.000 |
Why?
|
Incidence | 1 | 2002 | 20947 | 0.000 |
Why?
|
Exercise Test | 1 | 1991 | 2074 | 0.000 |
Why?
|
Health Status | 1 | 1997 | 4034 | 0.000 |
Why?
|
Patient Readmission | 1 | 1998 | 3114 | 0.000 |
Why?
|
Models, Theoretical | 1 | 1995 | 3589 | 0.000 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2001 | 9239 | 0.000 |
Why?
|
Diabetes Complications | 1 | 1989 | 1359 | 0.000 |
Why?
|
Health Services Accessibility | 1 | 1997 | 5137 | 0.000 |
Why?
|
Coronary Angiography | 1 | 1991 | 4577 | 0.000 |
Why?
|
Acute Disease | 1 | 1990 | 7149 | 0.000 |
Why?
|
Arrhythmias, Cardiac | 1 | 1989 | 2268 | 0.000 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 1995 | 9959 | 0.000 |
Why?
|
Pneumonia, Viral | 1 | 1996 | 3240 | 0.000 |
Why?
|
Tomography, X-Ray Computed | 1 | 2001 | 20129 | 0.000 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1988 | 3336 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 35421 | 0.000 |
Why?
|
Heart Failure | 1 | 1996 | 10900 | 0.000 |
Why?
|
Pregnancy | 1 | 1988 | 29144 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 1988 | 11725 | 0.000 |
Why?
|